Doxacurium chloride
A non-depolarizing neuromuscular blocking agent
| Doxacurium chloride | |
|---|---|
|
|
Doxacurium chloride is a non-depolarizing neuromuscular blocking agent used in anesthesia to induce muscle relaxation during surgery or mechanical ventilation. It is a member of the benzylisoquinolinium class of neuromuscular blockers.
Mechanism of Action[edit]
Doxacurium chloride works by competitively inhibiting the action of acetylcholine at the neuromuscular junction. It binds to the nicotinic acetylcholine receptor on the motor end plate, preventing acetylcholine from binding and thus blocking the transmission of nerve impulses to the muscle.
Pharmacokinetics[edit]
Doxacurium chloride is administered intravenously. It has a slow onset and a long duration of action compared to other neuromuscular blockers. The drug is metabolized in the liver and excreted primarily in the urine.
Clinical Use[edit]
Doxacurium chloride is used to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. It is particularly useful in procedures that require prolonged muscle relaxation.
Side Effects[edit]
Common side effects of doxacurium chloride include hypotension, flushing, and bronchospasm. As with other neuromuscular blockers, there is a risk of prolonged paralysis and respiratory depression if not properly monitored.
Contraindications[edit]
Doxacurium chloride should not be used in patients with known hypersensitivity to the drug or any of its components. Caution is advised in patients with myasthenia gravis or other neuromuscular disorders.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian